HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • Will Improving Adherence Optimize Medication Use?
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • The HEOR & RWE Marketplace
    • Visit the Market Place
    • On-demand Webinar
  • Industry Events
    • 5 Tips for Trade Show Success
    • HE Innovation Webinar
    • Webinar Services from HealthEconomics.Com
    • View Conferences
    • View Webinars
    • View Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute
You are here: Home / Archives for Featured

Race Rarely at Top of Patient’s Medical Record

Even though differences in health outcomes between Black and white people are well-established, a small survey finds that patients' race is not routinely mentioned atop their electronic medical record. The survey looked at data from 1,200 patients, and checked for race in the first line of the EMR […]

more info 01/12/2021View Related Articles
Bookmark and Share

Drugmakers Raise Prices 3.3% in the New Year

This month pharmaceutical companies have increased list prices on hundreds of branded drugs -- mostly between 2-7% (with only a couple companies daring the optics of double-digit hikes). In aggregate, however, the rate of increase across a market basket of the most common branded therapies was lower […]

more info 01/12/2021View Related Articles
Bookmark and Share

ICER Identifies Most Significant 2019 US Drug-Price Hikes

ICER Logo

The Institute for Clinical and Economic Review (ICER) today published its latest report on Unsupported Price Increases (UPI) of prescription drugs in the United States. Among the top drugs with price increases in 2019 that had substantial effects on US spending, ICER determined that seven of 10 […]

more info 01/12/2021View Related Articles
Bookmark and Share

EQRx Scales Disruptive Model of Important New Medicines

EQRx, a company committed to developing and delivering important new medicines at lower prices, today announced that it has raised $500 million in Series B financing. Since launching a year ago, EQRx has raised approximately $750 million to advance its mission of bringing new medicines to treat […]

more info 01/11/2021View Related Articles
Bookmark and Share

[On-demand Webinar] Avalere 2021 Healthcare Industry Outlook

The accelerated changes and increased uncertainties in healthcare brought on by the COVID-19 pandemic will continue into 2021, and its impacts are likely to shape healthcare for years to come. While prevalent uncertainty is a given, the broad outline of a new era is already emerging. More than ever, […]

more info 01/11/2021View Related Articles
Bookmark and Share

Fishawack Health Acquires The Hive Health Group

Fishawack Health (Fishawack) is a leading global commercialization partner for the modern life sciences era. The company’s three core operating units—Commercial, Consulting, and Medical Communications—can be leveraged individually but are designed for dynamic collaboration, with expert teams […]

more info 01/11/2021View Related Articles
Bookmark and Share

Virtual ISPOR 2021 Abstracts Due & Reviewers Needed!

Virtual ISPOR 2021 offers you an opportunity to present your research virtually to the leading global conference for health economics and outcomes research. Submit today and contribute to the future of HEOR and the difference it is making in today’s global healthcare landscape. New This Year: […]

more info 01/11/2021View Related Articles
Bookmark and Share

The 5 Numbers That Will Define Healthcare Value in 2021

Real world studies of COVID-19’s impact on health care utilization are arriving daily and their continued publication throughout the next year will be the defining characteristic of HEOR in 2021. One systematic review (in preprint) has already reported on 81 such studies. In these studies, which […]

more info 01/11/2021View Related Articles
Bookmark and Share

Seniors Face Crushing Drug Costs as Congress Stalls on Capping Medicare Out-Of-Pockets

Unlike private health insurance, Medicare Part D drug plans have no cap on patients’ 5% coinsurance costs once they hit $6,550 in drug spending this year (up from $6,350 in 2020), except for very low-income beneficiaries. President-elect Biden favors a cap, and Democrats and Republicans in Congress […]

more info 01/08/2021View Related Articles
Bookmark and Share

Read Up On How Regulators Are Using RWE

RWE is playing a growing role in FDA approvals. According to an Aetion analysis, 49 percent of submissions for new drugs and biologics in 2019 included an RWE study. In 2020, that figure jumped to 75 percent. In Aetion’s growing library of FDA Decision Alerts, they share examples in which RWE was […]

more info 01/08/2021View Related Articles
Bookmark and Share

The Bane of Prior Authorization

In a STAT op-ed, Brian Barnett, a psychiatrist at the Cleveland Clinic, discusses the burden of completing prior authorizations to ensure patients can retain access to medications. While prior authorizations can be used to ethically and efficiently steer patients toward lower-cost, clinically […]

more info 01/08/2021View Related Articles
Bookmark and Share

Has COVID-19 Changed Prescription Drug Pricing Forever?

As the COVID-19 pandemic continues to disrupt our lives and health care system on a historic scale, it is worth considering whether it has also revolutionized drug development and pricing in a profound way. COVID-19 vaccines were produced in record time using a novel approach: Drug makers committed […]

more info 01/08/2021View Related Articles
Bookmark and Share

ICER To Release Final Assessment of Selected High-impact Drugs

ICER will be reviewing changes in the evidence base for each of these drugs and assess whether or not new clinical data exists that could suggest that the drugs could be significantly more beneficial for patients than what was previously understood. ICER published the final draft of its first UPI […]

more info 01/08/2021View Related Articles
Bookmark and Share

Enjoy AMCP Learn Programs Available to You

AMCP Learn provides numerous on-demand CPE programs that will help you with your goals. Enjoy programs like Navigating Changes in Clostridioides difficile Prevention and Treatment, Value-based Contracting, Fundamentals of Managed Care Pharmacy Certificate Programs, and more! […]

more info 01/07/2021View Related Articles
Bookmark and Share

Volunteer with AMCP Foundation

nurseWpatient

Give the gift of time by volunteering. The AMCP Foundation has opportunities for you to donate your time. Volunteering is a great way to be hands-on as you help fulfill our mission of research and education. Become a volunteer today! AMCP Foundation P&T Competition Judges(Apply by Jan. 17, […]

more info 01/07/2021View Related Articles
Bookmark and Share

The AMCP Podcast Powered by PopHealth Week Launches Next Week

AMCP is proud to partner with renowned health care experts Fred Goldstein and Gregg Masters from PopHealth Week to launch a podcast that fosters conversation about the biggest challenges facing managed care pharmacy and up-to-the minute hot topics.  They are shining the spotlight on leading voices […]

more info 01/07/2021View Related Articles
Bookmark and Share

Panalgo’s IHD Platform to Be Used by the EU Medicines Agency for Real-World Data Analytics

Panalgo, a leading healthcare analytics company, today announced that its Instant Health Data (IHD) platform will be used by the European Medicines Agency (EMA) to facilitate the analysis of real-world data. EMA will use IHD to undertake rapid analyses of Electronic Healthcare Data (EHDs) […]

more info 01/06/2021View Related Articles
Bookmark and Share

Tracing the Health Care Experience Informs Decision-making

Mapping the patient journey is a worthwhile exercise to undertake because it answers critical questions of interest to all health care stakeholders. The richness of patient journey mapping can help develop patient cohorts and assess effectiveness of therapeutics. Total health care utilization and […]

more info 01/06/2021View Related Articles
Bookmark and Share

Why Population Health Isn’t the ‘Virtuous’ Approach

Mark Ganz isn't a fan of healthcare's fixation on population health. Ganz, who recently left the role of CEO of Cambia Health Solutions, told Fierce Healthcare in a recent interview that looking at health through a population lens creates distance between the healthcare system and the patient […]

more info 01/06/2021View Related Articles
Bookmark and Share

Driving More Value and Cost Savings With SDOH Data

Getting a Social Determinant of Health (SDOH) initiative off the ground requires thoughtful coordination and analysis between analytics teams, clinicians, social workers and others, and buy-in from leadership. SDOH data includes details about income, education, race, gender and other social factors. […]

more info 01/06/2021View Related Articles
Bookmark and Share

ICER Seeks Applications for New Health Technology Assessment Fellowship

The Institute for Clinical and Economic Review (ICER) is now accepting applications for the inaugural cycle of a new Health Technology Assessment (HTA) Fellowship. The ICER HTA Fellowship is a paid full-time one-year program for post-master's and post-doctoral graduates that provides experiential […]

more info 01/05/2021View Related Articles
Bookmark and Share

RxSense Joins with Hy-Vee to Launch New PBM Vivid Clear Rx

RxSense was founded in 2015 with a singular focus on developing technology solutions that improve healthcare transparency and access to more affordable medications. RxSense also utilizes its advanced platform and direct contracts with the nation’s largest pharmacies (including CVS, Walmart and […]

more info 01/05/2021View Related Articles
Bookmark and Share

Healthcare Venture Launched by Amazon, JPMorgan and Berkshire Hathaway Goes Bust

Haven—the healthcare company formed by Amazon, JPMorgan Chase and Berkshire Hathaway—is apparently no more. The healthcare company began telling employees on Monday about plans to shut down by the end of next month, CNBC reported first on Monday morning. Haven was first announced in January 2018 as […]

more info 01/05/2021View Related Articles
Bookmark and Share

Hospitals Lose Another Attempt to Stave Off Price Transparency

A federal appeals court ruled against hospitals' efforts to stop regulators from forcing them to reveal the secret negotiated prices they reach with insurers, according to an opinion filed Tuesday. Hospitals were hoping for intervention from the D.C. Circuit Court of Appeals as the rule requires […]

more info 01/05/2021View Related Articles
Bookmark and Share

How Does Cost-Sharing Impact Spending Growth and Cost-Effective Treatments?

The growth of health care spending has been a longstanding policy concern. Over the years, several innovations have been proposed to lower levels of health care spending; however, their impact has been limited and not sustained over time. Costly new technology, while often an improvement to existing […]

more info 01/05/2021View Related Articles
Bookmark and Share

Impact of the Pandemic on Medical and Scientific Affairs

In the latest episode of Impetus Digital's Fireside Chat, Dr. Shurjeel Choudhri, SVP and Head, Medical and Scientific Affairs, Bayer Canada, joins me for a wide-ranging conversation on several hot topics in Pharma and healthcare. Among many other things, we explore innovative digital technologies, […]

more info 01/05/2021View Related Articles
Bookmark and Share

The Medical Science Liaison-DISC Personality Types Survey

The MSL role is constantly evolving and facing new challenges. MSLs are both scientific experts and relationship managers. As such, they are required to perform tasks that are extremely analytical and technical in nature, while being able to skilfully handle relationships on a human level. Each of […]

more info 01/04/2021View Related Articles
Bookmark and Share

Trends That Matter for COVID Vaccine Distribution

As details continue to emerge about the availability of COVID-19 vaccines and how they will be administered, the role that payers will play in the process is becoming clearer, AIS Health reported. It's imperative for health plans to do two key things at the same time, according to Katherine […]

more info 01/04/2021View Related Articles
Bookmark and Share

Drug Wholesale Prices Impact Payer Spending, Out-of-pocket Costs

Increases in drug wholesale list prices have a trickle-down effect that negatively impacts patient financial responsibility, such as out-of-pocket costs, and payer spending, according to a study published in JAMA Network Open. In recent years, the pharmaceutical industry has been scrutinized for […]

more info 01/04/2021View Related Articles
Bookmark and Share

Use of Real-world Evidence in Economic Assessments of Pharmaceuticals in the US

In a recent study, investigators from the University of Washington School of Pharmacy reviewed cost-effectiveness and budget impact analyses in final evidence reports of pharmaceuticals published by ICER, calculating total number of RWE uses and the proportion of model inputs informed by RWE per […]

more info 01/04/2021View Related Articles
Bookmark and Share

  • Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 117
  • Next Page

 

View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Conference of the Week:

Link of the Week:

Job of the Week:

Webinar of the Week:

White Papers

  • Payers: The New Catalysts of Better Health
  • A writer’s role in drug development: a guide to getting started in regulatory medical writing
  • Virtual Medical Conferences: The new normal?
  • How Healthy Are Your Market Access Programs? ​​​​​​​A guide to performing check-ups on pharmaceutical distribution and patient access programs
  • The Overlooked Patient: How payers can identify, engage and treat the vulnerable populations not participating in their own care
  • Unlocking the potential of a Chief Outcomes Officer
  • Pharma’s path for digital health solutions
  • Gartner 2020 Magic Quadrant for Data Science + Machine Learning Platforms
  • How Are Changing Reimbursement Models Affecting Denials?
  • Regulation and Market Climate Force the Issue of CDM Prices
  • The Missing C-Suite Role
  • Patient- or Participant-Generated Registries
  • Multinational Registries: Challenges and Opportunities
  • Managing Missing Data in Patient Registries
  • Biorepositories
  • Increasing Focus on the Patient in Patient Registries
  • DIA DIRECT: Real-World Data to Inform COVID-19 Response: Collaborating in the COVID-19 Evidence Accelerator
  • Demonstrating the Value of Drugs for Rare Diseases – 8 Common Challenges and How to Address Them Before They Arise
  • How to Put AI + Predictive Analytics To Work
  • Insurance Design and Pharmaceutical Innovation
  • Global Biosimilars Pathways and Clinical Development Activity
  • Telemedicine adoption grew in most EU5 markets as COVID mitigation measures took hold
  • Mitigating COVID-19-related healthcare disruption
  • Marketing during COVID-19: A guide for pharma solution providers
  • State of Patient Centricity 2020: Advancing from Patient-first Intentions to True Co-creation
  • Alternative Policies for Pricing Novel Vaccines and Drug Therapies for COVID-19
  • Bayesian Methodologies for COVID-19 Drugs, Devices and Biologics
  • Excellence In Payer Engagement: Strategic Outputs From A Roundtable Discussion
  • Evidence Generation and Communication: A Guide to Getting Started in HEOR/Market Access Medical Writing
  • Preparing for ICER assessments: key recommendations for manufacturers

Syndicated Reports

  • Pharmaceutical Payment System Market – Quantitative Analysis, Current and Future Trends, 2020 – 2027
  • The Future of Personalised Medicine: The Role of Simulation and Digital Twins
  • Medical Diagnostics: leveraging new opportunities from AI driven technology
  • Massive Growth in Digital Health Technology Market by Athenahealth, McKesson Corporation, Qualcomm, LifeWatch, AT & T, Cerner Corporation, Philips Healthcare, Cisco Systems
  • Real World Evidence: The Role of Medical Affairs
  • Pharmacy Benefit Management (PBM) – Industry Size 2019, Market Opportunities, Share Analysis up to 2025
  • Democrats and Drug Pricing
  • Global Health Economics & Outcomes Research (HEOR) Services Market Size, Share, Growth, Status and Forecast 2019-2025
  • Global Value-Based Reimbursement Software Market Size, Status and Forecast to 2026
  • Benchmarking Key Account Management Capabilities (2019)
  • The Future of Key Account Management in Pharma
  • Indication-level Pricing: Payer Insights
  • Real-World Data Capabilities: Benchmarking Pharma Companies (2019)
  • Success in Managed Markets: Payer Insights
  • Real World Data and Evidence: Payer Insights
  • KAM Metrics: Measuring Success (2019)
  • Biomarkers and Companion diagnostics: Payer Insights
  • Paying for Digital Health: Payer Insights (2019)
  • Biosimilars: U.S. Market Analysis, Insights and Forecast, 2019-2026
  • Biosimilars: US Payer Insights (2019)
  • Review of Influence: The Institute for Clinical and Economic Review
  • Innovative Drugs: Mapping the Pricing and Reimbursement Landscape
  • Orphan Drugs: European Payer Perspectives
  • Do Payers Really Want Pay-for-Performance?
  • Payer Engagement: Benchmarking Team Structure and Activity
  • Benchmarking Market Access Strategies for High-Cost Drugs and Biologics
  • Blockchain: Transformational Change for Pharma?
  • HTA in Europe: Key Success Factors for Positive HTA Recommendations
  • Paying for Digital Health: Payer Insights
  • Benchmarking Pharma’s MSL Capabilities
HealthEconomics.Com

HealthEconomics.Com

  • Become a Better Writer!
  • HealthEconomics.Com Recognized as Top Influencer at ISPOR International Meeting in Washington DC
  • Will ICER Framework Destroy Progress Against Multiple Myeloma?
  • Celgene Unleashes the Power of Data into Clinical Trial Design
  • How Well is Harvoni Working in the Real World?
  • New CVS and Express Scripts Value Based Plans for Oncology
  • Oversized Cancer Drug Vials Waste $3B Each Year
  • Can More Data Make Providers’ Jobs Easier?
  • News
  • Conferences
  • Reports
  • Jobs
  • Consulting
  • Newsletters
  • White Papers

More Links

  • Take This Survey for a Chance to Win $200!
  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • ICER Releases Two Draft Reports on Obeticholic Acid
  • What do Patient Advocates Think of New ICER Report?
  • Could a New ICER Report Put Patients at Risk?
  • Contact Us

About

  • International Myeloma Foundation Responds to ICER Report
  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HE Institute

Strategy, Training, Education, and Communications in HEOR & Market Access.

Innovation Webinar

Big ideas accelerating change in HEOR, RWE and Health Technology. Learn more!

tHEORetically Speaking Blog

Insights and observations for HEOR, market access, pricing, reimbursement, and health policy.

HE Jobs Portal

Your Premier Employment Source for HEOR, Market Access, and Real World Evidence

HE Webinars

Online educational and informational seminars for HEOR, market access, pricing, and reimbursement.
  • Doctor Evidence Launches GROWTH Replicator Program
  • Is PCORI Underfunding CER?
  • HealthEconomics.Com
  • About HealthEconomics.Com
  • Advertising Inquiries
  • Careers
  • Contact HealthEconomics.Com

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • Will Improving Adherence Optimize Medication Use?
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • The HEOR & RWE Marketplace
    • Visit the Market Place
    • On-demand Webinar
  • Industry Events
    • 5 Tips for Trade Show Success
    • HE Innovation Webinar
    • Webinar Services from HealthEconomics.Com
    • View Conferences
    • View Webinars
    • View Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute